Japan Telemedicine Market - 2025-2033
Overview
The Japan telemedicine market reached US$ 5,142.91 million in 2024 and is expected to reach US$ 25,867.49 million by 2033, growing at a CAGR of 19.5% during the forecast period 2025-2033.
Telemedicine is a remote clinical service that allows real-time communication between patients and healthcare providers using electronic audio and visual means. It is particularly useful for chronic diseases like diabetes, high cholesterol, and high blood pressure, as it allows for assistance with dosage adjustments, lifestyle regimens, prescription refills, and group support. Telemedicine also aids in selecting urgent calls after a doctor's office is closed.
Market Dynamics: Drivers & Restraints
Growing Prevalence of Chronic Diseases
The telemedicine market in Japan is growing due to the increasing prevalence of chronic diseases, such as diabetes, hypertension, cardiovascular diseases, and respiratory disorders. For instance, in Japan, according to a NCBI study, over 90% of adults aged 75 or older have 1 chronic disease, and, of those, approximately 80% have multiple chronic diseases
Hence, Japan's aging population faces a high prevalence of chronic disease, increasing demand for continuous medical care. Telemedicine is crucial for efficient remote monitoring and management of multiple conditions, benefiting over 90% of seniors aged 75+, supporting market expansion, and reducing hospital burden.
Moreover, patients can also benefit from personalized treatment plans and lifestyle management programs. The integration of IoT-enabled health devices and mobile health applications allows real-time tracking of vital signs and symptoms, enabling proactive management of conditions.
Data Security and Privacy Concerns
Japan's telemedicine market faces significant challenges due to stringent regulatory requirements and the sensitive nature of health information. Telemedicine providers must comply with the Act on the Protection of Personal Information (APPI), which mandates explicit consent for collecting and using personal data, especially sensitive health information.
Cross-border data transfers are tightly regulated, requiring prior consent and assurance of adequate data protection standards. The Ministry of Health, Labour and Welfare enforces guidelines for robust cybersecurity measures, including multi-factor authentication, data encryption, access log monitoring, and regular software updates.
Moreover, data breaches can lead to severe penalties and loss of patient trust, emphasizing the need for stringent data protection measures.
Segment Analysis
The Japan telemedicine market is segmented based on type, care setting, and specialty area
Type:
Synchronous telemedicine segment is expected to dominate the telemedicine market share
Synchronous telemedicine is real-time communication between healthcare providers and patients via digital platforms like video conferencing, phone calls, or live chat. It allows immediate interaction, direct consultation, diagnosis, and treatment planning, making it beneficial for follow-up appointments, mental health consultations, and managing chronic conditions.
The synchronous telemedicine segment is growing due to the need for real-time consultations among aging and rural populations. The adoption of digital health tools is encouraged by rising awareness and acceptance. The Japanese government's policies, relaxed regulations, and reimbursement schemes for online medical services have also contributed to the growth. The COVID-19 pandemic has accelerated the shift towards real-time telehealth services, prompting hospitals and clinics to adopt synchronous solutions for continuity of care.
Competitive Landscape
The major country players in the telemedicine market include Medley Inc., Tokyo Medical and Surgical Clinic, SoftBank, JCOM Co., Ltd, DoctorMate Inc., and Integrity Healthcare Co., Ltd (YaDOC), among others.
Key Developments
Target Audience 2024
The Japan telemedicine market reached US$ 5,142.91 million in 2024 and is expected to reach US$ 25,867.49 million by 2033, growing at a CAGR of 19.5% during the forecast period 2025-2033.
Telemedicine is a remote clinical service that allows real-time communication between patients and healthcare providers using electronic audio and visual means. It is particularly useful for chronic diseases like diabetes, high cholesterol, and high blood pressure, as it allows for assistance with dosage adjustments, lifestyle regimens, prescription refills, and group support. Telemedicine also aids in selecting urgent calls after a doctor's office is closed.
Market Dynamics: Drivers & Restraints
Growing Prevalence of Chronic Diseases
The telemedicine market in Japan is growing due to the increasing prevalence of chronic diseases, such as diabetes, hypertension, cardiovascular diseases, and respiratory disorders. For instance, in Japan, according to a NCBI study, over 90% of adults aged 75 or older have 1 chronic disease, and, of those, approximately 80% have multiple chronic diseases
Hence, Japan's aging population faces a high prevalence of chronic disease, increasing demand for continuous medical care. Telemedicine is crucial for efficient remote monitoring and management of multiple conditions, benefiting over 90% of seniors aged 75+, supporting market expansion, and reducing hospital burden.
Moreover, patients can also benefit from personalized treatment plans and lifestyle management programs. The integration of IoT-enabled health devices and mobile health applications allows real-time tracking of vital signs and symptoms, enabling proactive management of conditions.
Data Security and Privacy Concerns
Japan's telemedicine market faces significant challenges due to stringent regulatory requirements and the sensitive nature of health information. Telemedicine providers must comply with the Act on the Protection of Personal Information (APPI), which mandates explicit consent for collecting and using personal data, especially sensitive health information.
Cross-border data transfers are tightly regulated, requiring prior consent and assurance of adequate data protection standards. The Ministry of Health, Labour and Welfare enforces guidelines for robust cybersecurity measures, including multi-factor authentication, data encryption, access log monitoring, and regular software updates.
Moreover, data breaches can lead to severe penalties and loss of patient trust, emphasizing the need for stringent data protection measures.
Segment Analysis
The Japan telemedicine market is segmented based on type, care setting, and specialty area
Type:
Synchronous telemedicine segment is expected to dominate the telemedicine market share
Synchronous telemedicine is real-time communication between healthcare providers and patients via digital platforms like video conferencing, phone calls, or live chat. It allows immediate interaction, direct consultation, diagnosis, and treatment planning, making it beneficial for follow-up appointments, mental health consultations, and managing chronic conditions.
The synchronous telemedicine segment is growing due to the need for real-time consultations among aging and rural populations. The adoption of digital health tools is encouraged by rising awareness and acceptance. The Japanese government's policies, relaxed regulations, and reimbursement schemes for online medical services have also contributed to the growth. The COVID-19 pandemic has accelerated the shift towards real-time telehealth services, prompting hospitals and clinics to adopt synchronous solutions for continuity of care.
Competitive Landscape
The major country players in the telemedicine market include Medley Inc., Tokyo Medical and Surgical Clinic, SoftBank, JCOM Co., Ltd, DoctorMate Inc., and Integrity Healthcare Co., Ltd (YaDOC), among others.
Key Developments
- In April 2024, Japan's internal affairs ministry is launched an initiative to offer online doctor consultations and medication guidance through private booths at post offices, with drugs delivered via postal service.
- In June 2024, Infosys partnered with Japan's dispensing pharmacy chain, Nihon Chouzai, to improve healthcare access in Japan. The partnership includes the development of a mobile application, NiCOMS, which offers remote medication guidance from registered pharmacists, eliminating the need for pharmacy visits.
- Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
- Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
- Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
- Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
- Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
- Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
- Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
- Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
- Countryal Growth & Investment: Highlights high-growth Countrys and investment opportunities.
- Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
- Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
- Post-market Surveillance: Uses post-market data to enhance product safety and access.
- Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.
Target Audience 2024
- Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
- Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
- Speciality Area & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
- Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
- Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
- Supply Chain: Distribution and Supply Chain Managers.
- Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
- Academic & Research: Academic Institutions.
1. METHODOLOGY AND SCOPE
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Snippet by Type
3.2. Snippet by Care Setting
3.3. Snippet by Specialty Area
3.4. Snippet by Country
4. DYNAMICS
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Growing Prevalence of Chronic Diseases
4.1.1.2. Rise in Aging Population and Healthcare Demand in Japan
4.1.1.3. XX
4.1.2. Restraints
4.1.2.1. Data Security and Privacy Concerns
4.1.2.2. Regulatory Challenges
4.1.2.3. XX
4.1.3. Opportunity
4.1.3.1. Expansion of Telepsychiatry and Mental Health Services
4.1.4. Impact Analysis
5. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
5.1. Market Leaders and Pioneers
5.1.1. Emerging Pioneers and Prominent Players
5.1.2. Established leaders with largest largest-selling Brand
5.1.3. Market leaders with established Product
5.2. CXO Perspectives
5.3. Latest Developments and Breakthroughs
5.4. Case Studies/Ongoing Research
5.5. Regulatory and Reimbursement Landscape
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. South America
5.5.5. Middle East & Africa
5.6. Porter’s Five Force Analysis
5.7. Supply Chain Analysis
5.8. Patent Analysis
5.9. SWOT Analysis
5.10. Unmet Needs and Gaps
5.11. Recommended Strategies for Market Entry and Expansion
5.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
5.13. Pricing Analysis and Price Dynamics
5.14. Key Opinion Leaders
6. BY TYPE
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
6.1.2. Market Attractiveness Index, By Type
6.2. Synchronous Telemedicine*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Asynchronous Telemedicine
6.4. Remote Patient Monitoring
6.5. mHealth
7. BY CARE SETTING
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Care Setting
7.1.2. Market Attractiveness Index, By Care Setting
7.2. Telehospital/Clinic*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Telehome
8. BY SPECIALTY AREA
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Specialty Area
8.1.2. Market Attractiveness Index, By Specialty Area
8.2. Dermatology*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Oncology
8.4. Cardiology
8.5. Psychiatry
8.6. Pathology
8.7. Others
9. COMPETITIVE LANDSCAPE
9.1. Competitive Scenario
9.2. Market Positioning/Share Analysis
9.3. Mergers and Acquisitions Analysis
10. COMPANY PROFILES
Key Market Players
10.1. Medley Inc*
10.1.1. Company Overview
10.1.2. Product Portfolio
10.1.2.1. Product Description
10.1.2.2. Product Key Performance Indicators (KPIs)
10.1.2.3. Historic and Forecasted Product Sales
10.1.2.4. Product Sales Volume
10.1.3. Financial Overview
10.1.3.1. Company Revenue’s
10.1.3.2. Geographical Revenue Shares
10.1.3.3. Revenue Forecasts
10.1.4. Key Developments
10.1.4.1. Mergers & Acquisitions
10.1.4.2. Key Product Development Activities
10.1.4.3. Regulatory Approvals etc.
10.1.5. SWOT Analysis
10.2. Tokyo Medical and Surgical Clinic
10.3. SoftBank
10.4. JCOM Co., Ltd
10.5. DoctorMate Inc
10.6. Integrity Healthcare Co., Ltd(YaDOC)
LIST NOT EXHAUSTIVE
11. ASSUMPTIONS AND RESEARCH METHODOLOGY
11.1 Data Collection Methods
11.2 Data Triangulation
11.3 Forecasting Techniques
11.4 Data Verification and Validation
12. APPENDIX
12.1 About Us and Services
12.2 Contact Us
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Snippet by Type
3.2. Snippet by Care Setting
3.3. Snippet by Specialty Area
3.4. Snippet by Country
4. DYNAMICS
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Growing Prevalence of Chronic Diseases
4.1.1.2. Rise in Aging Population and Healthcare Demand in Japan
4.1.1.3. XX
4.1.2. Restraints
4.1.2.1. Data Security and Privacy Concerns
4.1.2.2. Regulatory Challenges
4.1.2.3. XX
4.1.3. Opportunity
4.1.3.1. Expansion of Telepsychiatry and Mental Health Services
4.1.4. Impact Analysis
5. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
5.1. Market Leaders and Pioneers
5.1.1. Emerging Pioneers and Prominent Players
5.1.2. Established leaders with largest largest-selling Brand
5.1.3. Market leaders with established Product
5.2. CXO Perspectives
5.3. Latest Developments and Breakthroughs
5.4. Case Studies/Ongoing Research
5.5. Regulatory and Reimbursement Landscape
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. South America
5.5.5. Middle East & Africa
5.6. Porter’s Five Force Analysis
5.7. Supply Chain Analysis
5.8. Patent Analysis
5.9. SWOT Analysis
5.10. Unmet Needs and Gaps
5.11. Recommended Strategies for Market Entry and Expansion
5.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
5.13. Pricing Analysis and Price Dynamics
5.14. Key Opinion Leaders
6. BY TYPE
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
6.1.2. Market Attractiveness Index, By Type
6.2. Synchronous Telemedicine*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Asynchronous Telemedicine
6.4. Remote Patient Monitoring
6.5. mHealth
7. BY CARE SETTING
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Care Setting
7.1.2. Market Attractiveness Index, By Care Setting
7.2. Telehospital/Clinic*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Telehome
8. BY SPECIALTY AREA
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Specialty Area
8.1.2. Market Attractiveness Index, By Specialty Area
8.2. Dermatology*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Oncology
8.4. Cardiology
8.5. Psychiatry
8.6. Pathology
8.7. Others
9. COMPETITIVE LANDSCAPE
9.1. Competitive Scenario
9.2. Market Positioning/Share Analysis
9.3. Mergers and Acquisitions Analysis
10. COMPANY PROFILES
Key Market Players
10.1. Medley Inc*
10.1.1. Company Overview
10.1.2. Product Portfolio
10.1.2.1. Product Description
10.1.2.2. Product Key Performance Indicators (KPIs)
10.1.2.3. Historic and Forecasted Product Sales
10.1.2.4. Product Sales Volume
10.1.3. Financial Overview
10.1.3.1. Company Revenue’s
10.1.3.2. Geographical Revenue Shares
10.1.3.3. Revenue Forecasts
10.1.4. Key Developments
10.1.4.1. Mergers & Acquisitions
10.1.4.2. Key Product Development Activities
10.1.4.3. Regulatory Approvals etc.
10.1.5. SWOT Analysis
10.2. Tokyo Medical and Surgical Clinic
10.3. SoftBank
10.4. JCOM Co., Ltd
10.5. DoctorMate Inc
10.6. Integrity Healthcare Co., Ltd(YaDOC)
LIST NOT EXHAUSTIVE
11. ASSUMPTIONS AND RESEARCH METHODOLOGY
11.1 Data Collection Methods
11.2 Data Triangulation
11.3 Forecasting Techniques
11.4 Data Verification and Validation
12. APPENDIX
12.1 About Us and Services
12.2 Contact Us
LIST OF TABLES
Table 1 Japan Telemedicine Market Value, By Type, 2024, 2029 & 2033 (US$ Million)
Table 2 Japan Telemedicine Market Value, By Care Setting, 2024, 2029 & 2033 (US$ Million)
Table 3 Japan Telemedicine Market Value, By Speciality Area, 2024, 2029 & 2033 (US$ Million)
Table 4 Japan Telemedicine Market Value, By Type, 2024, 2029 & 2033 (US$ Million)
Table 5 Japan Telemedicine Market Value, By Type, 2018-2033 (US$ Million)
Table 6 Japan Telemedicine Market Value, By Care Setting, 2024, 2029 & 2033 (US$ Million)
Table 7 Japan Telemedicine Market Value, By Care Setting, 2018-2033 (US$ Million)
Table 8 Japan Telemedicine Market Value, By Speciality Area, 2024, 2029 & 2033 (US$ Million)
Table 9 Japan Telemedicine Market Value, By Speciality Area, 2018-2033 (US$ Million)
Table 10 Medley Inc: Overview
Table 11 Medley Inc: Product Portfolio
Table 12 Medley Inc: Key Developments
Table 13 Tokyo Medical and Surgical Clinic: Overview
Table 14 Tokyo Medical and Surgical Clinic: Product Portfolio
Table 15 Tokyo Medical and Surgical Clinic: Key Developments
Table 16 SoftBank: Overview
Table 17 SoftBank: Product Portfolio
Table 18 SoftBank: Key Developments
Table 19 JCOM Co., Ltd: Overview
Table 20 JCOM Co., Ltd: Product Portfolio
Table 21 JCOM Co., Ltd: Key Developments
Table 22 DoctorMate Inc: Overview
Table 23 DoctorMate Inc: Product Portfolio
Table 24 DoctorMate Inc: Key Developments
Table 25 Integrity Healthcare Co., Ltd (YaDOC): Overview
Table 26 Integrity Healthcare Co., Ltd (YaDOC): Product Portfolio
Table 27 Integrity Healthcare Co., Ltd (YaDOC): Key Developments
Table 1 Japan Telemedicine Market Value, By Type, 2024, 2029 & 2033 (US$ Million)
Table 2 Japan Telemedicine Market Value, By Care Setting, 2024, 2029 & 2033 (US$ Million)
Table 3 Japan Telemedicine Market Value, By Speciality Area, 2024, 2029 & 2033 (US$ Million)
Table 4 Japan Telemedicine Market Value, By Type, 2024, 2029 & 2033 (US$ Million)
Table 5 Japan Telemedicine Market Value, By Type, 2018-2033 (US$ Million)
Table 6 Japan Telemedicine Market Value, By Care Setting, 2024, 2029 & 2033 (US$ Million)
Table 7 Japan Telemedicine Market Value, By Care Setting, 2018-2033 (US$ Million)
Table 8 Japan Telemedicine Market Value, By Speciality Area, 2024, 2029 & 2033 (US$ Million)
Table 9 Japan Telemedicine Market Value, By Speciality Area, 2018-2033 (US$ Million)
Table 10 Medley Inc: Overview
Table 11 Medley Inc: Product Portfolio
Table 12 Medley Inc: Key Developments
Table 13 Tokyo Medical and Surgical Clinic: Overview
Table 14 Tokyo Medical and Surgical Clinic: Product Portfolio
Table 15 Tokyo Medical and Surgical Clinic: Key Developments
Table 16 SoftBank: Overview
Table 17 SoftBank: Product Portfolio
Table 18 SoftBank: Key Developments
Table 19 JCOM Co., Ltd: Overview
Table 20 JCOM Co., Ltd: Product Portfolio
Table 21 JCOM Co., Ltd: Key Developments
Table 22 DoctorMate Inc: Overview
Table 23 DoctorMate Inc: Product Portfolio
Table 24 DoctorMate Inc: Key Developments
Table 25 Integrity Healthcare Co., Ltd (YaDOC): Overview
Table 26 Integrity Healthcare Co., Ltd (YaDOC): Product Portfolio
Table 27 Integrity Healthcare Co., Ltd (YaDOC): Key Developments
LIST OF FIGURES
Figure 1 Japan Telemedicine Market Value, 2018-2033 (US$ Million)
Figure 2 Japan Telemedicine Market Share, By Type, 2024 & 2033 (%)
Figure 3 Japan Telemedicine Market Share, By Care Setting, 2024 & 2033 (%)
Figure 4 Japan Telemedicine Market Share, By Speciality Area, 2024 & 2033 (%)
Figure 5 Japan Telemedicine Market Y-o-Y Growth, By Type, 2024-2033 (%)
Figure 6 Synchronous Telemedicine Telemedicine Market Value, 2018-2033 (US$ Million)
Figure 7 Asynchronous Telemedicine Telemedicine Market Value, 2018-2033 (US$ Million)
Figure 8 Remote Patient Monitoring Telemedicine Market Value, 2018-2033 (US$ Million)
Figure 9 mHealth Telemedicine Market Value, 2018-2033 (US$ Million)
Figure 10 Japan Telemedicine Market Y-o-Y Growth, By Care Setting, 2024-2033 (%)
Figure 11 Telehospital/Clinic Care Setting in Japan Telemedicine Market Value, 2018-2033 (US$ Million)
Figure 12 Telehome Care Setting in Japan Telemedicine Market Value, 2018-2033 (US$ Million)
Figure 13 Japan Telemedicine Market Y-o-Y Growth, By Speciality Area, 2024-2033 (%)
Figure 14 Dermatology Speciality Area in Japan Telemedicine Market Value, 2018-2033 (US$ Million)
Figure 15 Oncology Speciality Area in Japan Telemedicine Market Value, 2018-2033 (US$ Million)
Figure 16 Cardiology Speciality Area in Japan Telemedicine Market Value, 2018-2033 (US$ Million)
Figure 17 Psychiatry Speciality Area in Japan Telemedicine Market Value, 2018-2033 (US$ Million)
Figure 18 Pathology Speciality Area in Japan Telemedicine Market Value, 2018-2033 (US$ Million)
Figure 19 Others Speciality Area in Japan Telemedicine Market Value, 2018-2033 (US$ Million)
Figure 20 Medley Inc: Financials
Figure 21 Tokyo Medical and Surgical Clinic: Financials
Figure 22 SoftBank: Financials
Figure 23 JCOM Co., Ltd: Financials
Figure 24 DoctorMate Inc: Financials
Figure 25 Integrity Healthcare Co., Ltd (YaDOC): Financials
Figure 1 Japan Telemedicine Market Value, 2018-2033 (US$ Million)
Figure 2 Japan Telemedicine Market Share, By Type, 2024 & 2033 (%)
Figure 3 Japan Telemedicine Market Share, By Care Setting, 2024 & 2033 (%)
Figure 4 Japan Telemedicine Market Share, By Speciality Area, 2024 & 2033 (%)
Figure 5 Japan Telemedicine Market Y-o-Y Growth, By Type, 2024-2033 (%)
Figure 6 Synchronous Telemedicine Telemedicine Market Value, 2018-2033 (US$ Million)
Figure 7 Asynchronous Telemedicine Telemedicine Market Value, 2018-2033 (US$ Million)
Figure 8 Remote Patient Monitoring Telemedicine Market Value, 2018-2033 (US$ Million)
Figure 9 mHealth Telemedicine Market Value, 2018-2033 (US$ Million)
Figure 10 Japan Telemedicine Market Y-o-Y Growth, By Care Setting, 2024-2033 (%)
Figure 11 Telehospital/Clinic Care Setting in Japan Telemedicine Market Value, 2018-2033 (US$ Million)
Figure 12 Telehome Care Setting in Japan Telemedicine Market Value, 2018-2033 (US$ Million)
Figure 13 Japan Telemedicine Market Y-o-Y Growth, By Speciality Area, 2024-2033 (%)
Figure 14 Dermatology Speciality Area in Japan Telemedicine Market Value, 2018-2033 (US$ Million)
Figure 15 Oncology Speciality Area in Japan Telemedicine Market Value, 2018-2033 (US$ Million)
Figure 16 Cardiology Speciality Area in Japan Telemedicine Market Value, 2018-2033 (US$ Million)
Figure 17 Psychiatry Speciality Area in Japan Telemedicine Market Value, 2018-2033 (US$ Million)
Figure 18 Pathology Speciality Area in Japan Telemedicine Market Value, 2018-2033 (US$ Million)
Figure 19 Others Speciality Area in Japan Telemedicine Market Value, 2018-2033 (US$ Million)
Figure 20 Medley Inc: Financials
Figure 21 Tokyo Medical and Surgical Clinic: Financials
Figure 22 SoftBank: Financials
Figure 23 JCOM Co., Ltd: Financials
Figure 24 DoctorMate Inc: Financials
Figure 25 Integrity Healthcare Co., Ltd (YaDOC): Financials
